UNSPSC 51161726: Dimefline hydrochloride

This classification denotes a cns stimulant with the molecular formula C20H21NO3.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H0XB4R74ID, chemically known as 4h-1-benzopyran-4-one, 8-((dimethylamino)methyl)-7-methoxy-3-methyl-2-phenyl- (9ci) but more generally known as dimefline hydrochloride, which bears US NIH Compound Identifier 3078. European Medicines Agency schedules Dimefline hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01738MIG.

UNSPSC 51161726 Dimefline hydrochloride is a Commodity code that appears in state and local procurement activity primarily for emergency response and healthcare delivery applications rather than the pharmaceutical compound itself. Recent solicitations show state and local governments using this code designation to procure naloxone (opioid-overdose reversal medication) and comprehensive pharmacy services, reflecting a practical focus on public-health interventions and employee health-plan administration. The issuing bodies include county health departments and county government benefits administrators procuring through competitive bidding and request-for-qualifications processes.

Activity concentrates in the Southeast, with documented recent opportunities in Florida and Georgia. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually for quarterly delivery to the Seminole County Community Health Building, with a July 26, 2023 response deadline and a two-year initial term plus one-year renewal option. Hall County, Georgia released RFQ/P #47-010 in May 2026 for on-site pharmacy services at the Hall County Government Family Health Center Clinic in Gainesville, serving approximately 3,005 eligible individuals across multiple health plan tiers, with an 80/20 technical-to-cost evaluation methodology, a June 4, 2026 proposal deadline, and a one-year initial contract beginning January 1, 2027 with four optional renewal years.